Elan Corporation plc (ELN) announced that, at its Extraordinary General Meeting, shareholders approved the share repurchase program. Elan shareholders did not approve the Theravance Transaction, the AOP Transaction or the ELND005 Transaction.
The company said, as its shareholders have approved the share repurchase program, and in accordance with the terms of the Royalty Pharma Offer, the Royalty Pharma Offer has now lapsed.
Elan invited Royalty Pharma to participate in the formal sale process, and to bring forward a new offer should it so desire.
For comments and feedback contact: editorial@rttnews.com
Business News
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.